United Therapeutics UTHR
NASDAQ UTHR
$505.40 +7.43 (+1.49%)
As of: Sep 9, 2026 · 3:10 PM EDT

United Therapeutics (UTHR) Prepaid Assets (2009 - 2026)

United Therapeutics' (UTHR) quarterly Prepaid Assets came in at $317.3 million in Q2 2026, up 38.14% year-over-year from $229.7 million in Q2 2025, and up 39.17% quarter-over-quarter from $228.0 million in Q1 2026.

Analysis

United Therapeutics (UTHR) Prepaid Assets (2009 - 2026) Analysis & Trends

United Therapeutics has disclosed Prepaid Assets across 18 years of filings, most recently posting $317.3 million for Q2 2026.

  • In Q2 2026, Prepaid Assets rose 38.14% year-over-year to $317.3 million; the TTM figure through Jun 2026 stood at $317.3 million (up 38.14% YoY), while the FY2025 annual figure was $248.9 million, up 46.67% from the prior year.
  • Prepaid Assets came in at $317.3 million for Q2 2026 at United Therapeutics, up from $228.0 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $317.3 million in Q2 2026 to a low of $60.2 million in Q1 2022.
  • Average Prepaid Assets over 5 years is $183.2 million, with a median of $177.5 million recorded in 2024.
  • Year-over-year, Prepaid Assets surged 118.33% in 2022 and fell 24.18% in 2023.
  • Over 5 years, Prepaid Assets stood at $219.2 million in 2022, then retreated by 24.18% to $166.2 million in 2023, then increased by 2.11% to $169.7 million in 2024, then surged by 46.67% to $248.9 million in 2025, then climbed by 27.48% to $317.3 million in 2026.
  • Per Business Quant data, the three most recent Prepaid Assets figures were $317.3 million in Q2 2026, $228.0 million in Q1 2026, and $248.9 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 646.43 Bn 625.67 Bn 17.26 Bn
2 AbbVie 442.46 Bn 435.89 Bn 12.70 Bn
3 Merck 366.77 Bn 359.63 Bn 12.21 Bn
4 Novartis Ag 266.59 Bn 258.90 Bn 11.24 Bn
5 Pfizer 159.14 Bn 147.45 Bn 10.94 Bn
6 Sanofi 52.40 Bn 45.02 Bn 10.79 Bn
7 Revolution Medicines 44.08 Bn 44.08 Bn -
8 Incyte 25.38 Bn 20.85 Bn 1.57 Bn
9 United Therapeutics 21.53 Bn 18.87 Bn 683.80 Mn
10 Neurocrine Biosciences 15.60 Bn 15.21 Bn 935.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 317.30 Mn
Mar 31, 2026 228.00 Mn
Dec 31, 2025 248.90 Mn
Sep 30, 2025 252.20 Mn
Jun 30, 2025 229.70 Mn
Mar 31, 2025 131.10 Mn
Dec 31, 2024 169.70 Mn
Sep 30, 2024 185.40 Mn
Jun 30, 2024 220.80 Mn
Mar 31, 2024 113.40 Mn
Dec 31, 2023 166.20 Mn
Sep 30, 2023 220.50 Mn
Jun 30, 2023 158.40 Mn
Mar 31, 2023 92.60 Mn
Dec 31, 2022 219.20 Mn
Sep 30, 2022 118.10 Mn
Jun 30, 2022 165.80 Mn
Mar 31, 2022 60.20 Mn
Dec 31, 2021 100.40 Mn
Sep 30, 2021 76.00 Mn